SOLID TUMOURS:@0.084848:0.038601:0.266058:0.038601:0.266058:0.019343:0.084848:0.019343:0.011712:0.020438:0.010866:0.005315:0.017498:0.006515:0.010019:0.015405:0.021613:0.020438:0.015405:0.014276:0.011712
42:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
recurrence rate from approximately 45% :@0.084242:0.096166:0.480488:0.096166:0.480488:0.080410:0.084242:0.080410:0.005905:0.012700:0.012642:0.011892:0.005984:0.005904:0.012700:0.011930:0.012642:0.012700:0.007428:0.005984:0.013335:0.006716:0.012700:0.007428:0.006235:0.005905:0.012796:0.018242:0.007428:0.013335:0.013316:0.013316:0.005904:0.012796:0.009429:0.004041:0.018242:0.013335:0.006716:0.012700:0.004041:0.010506:0.007428:0.010853:0.010853:0.014911:0.005330
to less than 10% .:@0.084242:0.112583:0.243954:0.112583:0.243954:0.096827:0.084242:0.096827:0.006716:0.012796:0.005523:0.004041:0.012700:0.007658:0.007658:0.005523:0.006716:0.011930:0.013335:0.011930:0.005523:0.010853:0.010853:0.015105:0.005523:0.005330
7:@0.244135:0.106961:0.250350:0.106961:0.250350:0.097775:0.244135:0.097775:0.006215
CHEMOTHERAPY:@0.084242:0.145732:0.251865:0.145732:0.251865:0.127917:0.084242:0.127917:0.016677:0.014539:0.011118:0.019242:0.017960:0.008980:0.014539:0.011118:0.012401:0.015822:0.011973:0.013256
The decision for adjuvant chemotherapy :@0.084242:0.163293:0.480509:0.163293:0.480509:0.147538:0.084242:0.147538:0.008197:0.011738:0.012508:0.007974:0.013181:0.012508:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.007986:0.006042:0.012604:0.005792:0.007986:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.007986:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
in adenocarcinoma of the colon is based :@0.084242:0.179711:0.480478:0.179711:0.480478:0.163955:0.084242:0.163955:0.003848:0.011738:0.005946:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005653:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005946:0.012604:0.006042:0.005946:0.006523:0.011738:0.012508:0.005946:0.012450:0.012604:0.003848:0.012604:0.011738:0.005946:0.003848:0.007466:0.005946:0.013123:0.013143:0.007466:0.012508:0.013181:0.005330
on the pathological stage of the tumour. :@0.084242:0.196128:0.480505:0.196128:0.480505:0.180372:0.084242:0.180372:0.012604:0.011738:0.007281:0.006523:0.011738:0.012508:0.007281:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.007293:0.007466:0.006523:0.013143:0.012950:0.012508:0.007293:0.012604:0.006042:0.007293:0.006523:0.011738:0.012508:0.007281:0.006523:0.011699:0.018049:0.012604:0.011699:0.004368:0.005330:0.005330
In general, stage I and II lesions that are :@0.084242:0.212546:0.480476:0.212546:0.480476:0.196790:0.084242:0.196790:0.004349:0.011738:0.008066:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330:0.008066:0.007466:0.006523:0.013143:0.012950:0.012508:0.008063:0.004349:0.008070:0.013143:0.011738:0.013181:0.008068:0.004349:0.004349:0.008072:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.008064:0.006523:0.011738:0.013143:0.006523:0.008063:0.013143:0.005715:0.012508:0.005330
completely resected do not require adju-:@0.084242:0.228963:0.475173:0.228963:0.475173:0.213207:0.084242:0.213207:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.003848:0.010314:0.006446:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.012508:0.013181:0.006446:0.013181:0.012604:0.006446:0.011738:0.012604:0.006523:0.006433:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.006446:0.013143:0.013181:0.003906:0.011699:0.006388
vant chemotherapy since the risk of recur-:@0.084242:0.245380:0.475183:0.245380:0.475183:0.229625:0.084242:0.229625:0.010660:0.013143:0.011738:0.006523:0.004945:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004930:0.007466:0.003848:0.011738:0.012450:0.012508:0.004945:0.006523:0.011738:0.012508:0.004945:0.005792:0.003848:0.007466:0.009660:0.004945:0.012604:0.006042:0.004936:0.005713:0.012508:0.012450:0.011699:0.005792:0.006388
rence is low. However, stage II lesions that :@0.084242:0.261798:0.480501:0.261798:0.480501:0.246042:0.084242:0.246042:0.005713:0.012508:0.011738:0.012450:0.012508:0.005952:0.003848:0.007466:0.005965:0.003848:0.012604:0.015990:0.005330:0.005956:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003768:0.005330:0.005956:0.007466:0.006523:0.013143:0.012950:0.012508:0.005965:0.004349:0.004349:0.005965:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.005965:0.006523:0.011738:0.013143:0.006523:0.005330
have high-risk features, such as T4-stage, :@0.084242:0.278215:0.480474:0.278215:0.480474:0.262459:0.084242:0.262459:0.011738:0.013143:0.010660:0.012508:0.008274:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.008274:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.007466:0.005330:0.008274:0.007466:0.011699:0.012450:0.011738:0.008274:0.013143:0.007466:0.008274:0.008197:0.010660:0.006388:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.005330
lymphovascular invasion, poor  differen-:@0.084242:0.294633:0.475156:0.294633:0.475156:0.278877:0.084242:0.278877:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.010660:0.013143:0.007466:0.012450:0.011699:0.003848:0.013143:0.005792:0.013508:0.003848:0.011738:0.010660:0.013143:0.007466:0.003848:0.012604:0.011738:0.005330:0.013508:0.013123:0.012604:0.012604:0.005792:0.005330:0.008165:0.013181:0.003848:0.006102:0.006042:0.012508:0.005711:0.012508:0.011738:0.006388
tiation or tumours that perforate or cause :@0.084242:0.311050:0.480520:0.311050:0.480520:0.295294:0.084242:0.295294:0.006523:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006331:0.012604:0.005792:0.006331:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.006331:0.006523:0.011738:0.013143:0.006523:0.006321:0.013123:0.012508:0.006708:0.006042:0.012604:0.005792:0.013143:0.006523:0.012508:0.006321:0.012604:0.005792:0.006319:0.012450:0.013143:0.011699:0.007466:0.012508:0.005330
bowel  obstruction,  may  benefit  from :@0.084242:0.327467:0.480492:0.327467:0.480492:0.311711:0.084242:0.311711:0.013123:0.012604:0.015990:0.012508:0.003848:0.005330:0.013041:0.012604:0.013123:0.007466:0.006523:0.005792:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.013029:0.018049:0.013143:0.010314:0.005330:0.013044:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.005330:0.013027:0.006042:0.005711:0.012604:0.018049:0.005330
adjuvant chemotherapy,  although  the :@0.084242:0.343885:0.480490:0.343885:0.480490:0.328129:0.084242:0.328129:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.015375:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.010029:0.013143:0.003848:0.006523:0.011738:0.012604:0.011699:0.012950:0.011738:0.005330:0.010029:0.006523:0.011738:0.012508:0.005330
evidence for this is limited. There is a sig-:@0.084242:0.360302:0.475131:0.360302:0.475131:0.344546:0.084242:0.344546:0.012508:0.010660:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.007909:0.006042:0.012604:0.005792:0.007899:0.006523:0.011738:0.003848:0.007466:0.007909:0.003848:0.007466:0.007909:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.005330:0.007909:0.008197:0.011738:0.012508:0.005703:0.012508:0.007909:0.003848:0.007466:0.007909:0.013143:0.007909:0.007466:0.003848:0.012950:0.006388
nificant decrease in risk of recurrence for :@0.084242:0.376720:0.480492:0.376720:0.480492:0.360964:0.084242:0.360964:0.011738:0.003848:0.004686:0.004686:0.012450:0.013143:0.011738:0.006523:0.007351:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.007358:0.003848:0.011738:0.007358:0.005792:0.003848:0.007466:0.009660:0.007360:0.012604:0.006042:0.007353:0.005711:0.012508:0.012450:0.011699:0.005792:0.005707:0.012508:0.011738:0.012450:0.012508:0.007349:0.006042:0.012604:0.005792:0.005330
patients with stage III disease who receive :@0.084242:0.393137:0.480472:0.393137:0.480472:0.377381:0.084242:0.377381:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005272:0.015990:0.003848:0.006523:0.011738:0.005272:0.007466:0.006523:0.013143:0.012950:0.012508:0.005272:0.004349:0.004349:0.004349:0.005272:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005286:0.015990:0.011738:0.012604:0.005272:0.005711:0.012508:0.012450:0.012508:0.003848:0.010660:0.012508:0.005330
adjuvant chemotherapy,  the standard :@0.084242:0.409554:0.480490:0.409554:0.480490:0.393798:0.084242:0.393798:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.015432:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.010089:0.006523:0.011738:0.012508:0.015432:0.007466:0.006523:0.013143:0.011738:0.013181:0.013143:0.005678:0.013181:0.005330
regimen being a combination of intrave-:@0.084242:0.425972:0.475167:0.425972:0.475167:0.410216:0.084242:0.410216:0.005713:0.012508:0.012950:0.003848:0.018049:0.012508:0.011738:0.007472:0.013123:0.012508:0.003848:0.011738:0.012950:0.007485:0.013143:0.007485:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.007472:0.012604:0.006042:0.007472:0.003848:0.011738:0.006523:0.005792:0.013143:0.010660:0.012508:0.006388
nous  5-fluorouracil  (5FU),  leucovorin  and :@0.084242:0.442389:0.480476:0.442389:0.480476:0.426633:0.084242:0.426633:0.011738:0.012604:0.011699:0.007466:0.005330:0.004589:0.010660:0.006388:0.004666:0.004666:0.011699:0.012604:0.005705:0.012604:0.011699:0.005780:0.013143:0.012450:0.003848:0.003848:0.005330:0.004605:0.007100:0.010660:0.009333:0.012604:0.007100:0.005330:0.005330:0.004593:0.003848:0.012508:0.011699:0.012450:0.012604:0.010660:0.012604:0.005792:0.003848:0.011738:0.005330:0.004585:0.013143:0.011738:0.013181:0.005330
oxaliplatin or oral 5FU (capecitabine) and :@0.084242:0.458807:0.480472:0.458807:0.480472:0.443051:0.084242:0.443051:0.012604:0.009236:0.013143:0.003848:0.003848:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005792:0.012604:0.005792:0.005782:0.012604:0.005792:0.013143:0.003848:0.005792:0.010660:0.009333:0.012604:0.005792:0.007100:0.012450:0.013143:0.013123:0.012508:0.012450:0.003848:0.006523:0.013143:0.013123:0.003848:0.011738:0.012508:0.007100:0.005792:0.013143:0.011738:0.013181:0.005330
oxaliplatin.  Chemotherapy  is generally :@0.084242:0.475224:0.480491:0.475168:0.480491:0.459412:0.084242:0.459468:0.012604:0.009236:0.013143:0.003848:0.003848:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330:0.006226:0.014278:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.008927:0.003848:0.007466:0.014278:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.003848:0.010314:0.311148
8:@0.184485:0.469549:0.190700:0.469549:0.190700:0.460364:0.184485:0.460364:0.006215
given for a period of six months and should :@0.084234:0.491586:0.480443:0.491586:0.480443:0.475830:0.084234:0.475830:0.012950:0.003848:0.010660:0.012508:0.011738:0.004330:0.006042:0.012604:0.005792:0.004330:0.013143:0.004330:0.013123:0.012508:0.005792:0.003848:0.012604:0.013181:0.004330:0.012604:0.006042:0.004330:0.007466:0.003848:0.009236:0.004330:0.018049:0.012604:0.011738:0.006523:0.011726:0.007466:0.004330:0.013143:0.011738:0.013181:0.004330:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005330
start  within four  to  six weeks  of  surgery, :@0.084234:0.508003:0.480491:0.508003:0.480491:0.492247:0.084234:0.492247:0.007466:0.006523:0.013143:0.005792:0.006523:0.005330:0.005143:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.010487:0.006042:0.012604:0.011699:0.005792:0.005330:0.005136:0.006523:0.012604:0.005330:0.005140:0.007466:0.003848:0.009236:0.010487:0.015990:0.012508:0.012508:0.009660:0.007466:0.005330:0.005147:0.012604:0.006042:0.005330:0.005142:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.005330:0.005330
although  a recent pooled analysis  has :@0.084234:0.524421:0.480478:0.524421:0.480478:0.508665:0.084234:0.508665:0.013143:0.003848:0.006523:0.011738:0.012604:0.011699:0.012950:0.011738:0.005330:0.006839:0.013143:0.012180:0.005711:0.012508:0.012450:0.012508:0.011738:0.006523:0.012180:0.013123:0.012604:0.012604:0.003848:0.012508:0.013181:0.012180:0.013143:0.011738:0.013143:0.003848:0.010314:0.007466:0.003848:0.007466:0.005330:0.006870:0.011738:0.013143:0.007466:0.005330
shown that three months in low-risk stage :@0.084234:0.540838:0.480493:0.540838:0.480493:0.525082:0.084234:0.525082:0.007466:0.011738:0.012604:0.015990:0.011738:0.007100:0.006523:0.011738:0.013143:0.006523:0.007100:0.006523:0.011738:0.005707:0.012508:0.012508:0.007100:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.007089:0.003848:0.011738:0.007100:0.003848:0.012604:0.015990:0.006388:0.005792:0.003848:0.007466:0.009660:0.007100:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330
III  patients  may  be  sufficient  for  patients :@0.084234:0.557255:0.480466:0.557255:0.480466:0.541499:0.084234:0.541499:0.004349:0.004349:0.004349:0.005330:0.003823:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.003818:0.018049:0.013143:0.010314:0.005330:0.003823:0.013123:0.012508:0.005330:0.003820:0.007466:0.011699:0.006042:0.004686:0.004686:0.012450:0.003848:0.012508:0.011738:0.006523:0.005330:0.003814:0.006042:0.012604:0.005792:0.005330:0.003812:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
receiving the combination of 5FU and ox-:@0.084234:0.573673:0.475142:0.573673:0.475142:0.557917:0.084234:0.557917:0.005713:0.012508:0.012450:0.012508:0.003848:0.010660:0.003848:0.011738:0.012950:0.006119:0.006523:0.011738:0.012508:0.006119:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.006119:0.012604:0.006042:0.006119:0.010660:0.009333:0.012604:0.006119:0.013143:0.011738:0.013181:0.006119:0.012604:0.009236:0.006388
aliplatin, whereas for  patients  receiving :@0.084234:0.590090:0.480474:0.590090:0.480474:0.574334:0.084234:0.574334:0.013143:0.003848:0.003848:0.013123:0.003848:0.013143:0.006523:0.003848:0.011738:0.005330:0.011988:0.015990:0.011738:0.012508:0.005707:0.012508:0.013143:0.007466:0.011988:0.006042:0.012604:0.005792:0.005330:0.006639:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.006648:0.005713:0.012508:0.012450:0.012508:0.003848:0.010660:0.003848:0.011738:0.012950:0.005330
5FU alone, the full six months of treatment :@0.084234:0.606508:0.480497:0.606508:0.480497:0.590752:0.084234:0.590752:0.010660:0.009333:0.012604:0.006061:0.013143:0.003848:0.012604:0.011738:0.012508:0.005330:0.006061:0.006523:0.011738:0.012508:0.006061:0.006042:0.011699:0.003848:0.003848:0.006061:0.007466:0.003848:0.009236:0.006061:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.006052:0.012604:0.006042:0.006061:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
should be given.:@0.084234:0.622925:0.238096:0.622925:0.238096:0.607169:0.084234:0.607169:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005330:0.013123:0.012508:0.005330:0.012950:0.003848:0.010660:0.012508:0.011738:0.005330
9:@0.238097:0.617280:0.244312:0.617280:0.244312:0.608094:0.238097:0.608094:0.006215
RADIATION:@0.084242:0.656051:0.197986:0.656051:0.197986:0.638236:0.084242:0.638236:0.012401:0.015822:0.014966:0.005987:0.015822:0.008980:0.005987:0.017960:0.015822
Neoadjuvant  radiation has been  shown :@0.084242:0.673612:0.480494:0.673612:0.480494:0.657856:0.084242:0.657856:0.014239:0.012508:0.012604:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.005330:0.005163:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.010506:0.011738:0.013143:0.007466:0.010506:0.013123:0.012508:0.012508:0.011738:0.005330:0.005163:0.007466:0.011738:0.012604:0.015990:0.011738:0.005330
in a number of trials to  reduce local re-:@0.084242:0.690029:0.475177:0.690029:0.475177:0.674274:0.084242:0.674274:0.003848:0.011738:0.009044:0.013143:0.009044:0.011738:0.011699:0.018049:0.013123:0.012508:0.005792:0.009044:0.012604:0.006042:0.009044:0.006523:0.005792:0.003848:0.013143:0.003848:0.007466:0.009044:0.006523:0.012604:0.005330:0.003704:0.005713:0.012508:0.013181:0.011699:0.012450:0.012508:0.009044:0.003848:0.012604:0.012450:0.013143:0.003848:0.009044:0.005713:0.012508:0.006388
currence in adenocarcinoma of the rec-:@0.084242:0.706447:0.475161:0.706447:0.475161:0.690691:0.084242:0.690691:0.012450:0.011699:0.005792:0.005705:0.012508:0.011738:0.012450:0.012508:0.007549:0.003848:0.011738:0.007562:0.013143:0.013181:0.012508:0.011738:0.012604:0.012450:0.013143:0.005651:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.007553:0.012604:0.006042:0.007551:0.006523:0.011738:0.012508:0.007547:0.005713:0.012508:0.012450:0.006388
tum.  In patients with resectable tumours :@0.084242:0.722864:0.480505:0.722856:0.480505:0.707100:0.084242:0.707108:0.006523:0.011699:0.018049:0.005330:0.012427:0.006841:0.004349:0.011738:0.006841:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006850:0.015990:0.003848:0.006523:0.011738:0.006841:0.005713:0.012508:0.007466:0.012508:0.012450:0.006523:0.013143:0.013123:0.003848:0.012508:0.006850:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:-0.049139
10:@0.125837:0.717237:0.138267:0.717237:0.138267:0.708051:0.125837:0.708051:0.006215:0.006215
where there is a concern about local con-:@0.084239:0.739273:0.475167:0.739273:0.475167:0.723517:0.084239:0.723517:0.015990:0.011738:0.012508:0.005709:0.012508:0.004739:0.006523:0.011738:0.012508:0.005705:0.012508:0.004739:0.003848:0.007466:0.004753:0.013143:0.004743:0.012450:0.012604:0.011738:0.012450:0.012508:0.006183:0.011738:0.004737:0.013143:0.013123:0.012604:0.011699:0.006523:0.004737:0.003848:0.012604:0.012450:0.013143:0.003848:0.004753:0.012450:0.012604:0.011738:0.006388
trol,  short-course radiation,  i.e.,  25 Grey :@0.084239:0.755690:0.480492:0.755690:0.480492:0.739934:0.084239:0.739934:0.006523:0.005709:0.012604:0.003848:0.005330:0.005330:0.005819:0.007466:0.011738:0.012604:0.005792:0.006523:0.006388:0.012450:0.012604:0.011699:0.005775:0.007466:0.012508:0.011161:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.005817:0.003848:0.005330:0.012508:0.005330:0.005330:0.005330:0.005815:0.010660:0.010660:0.011161:0.016779:0.005715:0.012508:0.010314:0.005330
(Gy) in five daily fractions with surgery the :@0.084239:0.772108:0.480484:0.772108:0.480484:0.756352:0.084239:0.756352:0.007100:0.016779:0.010314:0.007100:0.006029:0.003848:0.011738:0.006021:0.004686:0.004686:0.010660:0.012508:0.006019:0.013181:0.013143:0.003848:0.003848:0.010314:0.006034:0.006042:0.005792:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.006013:0.015990:0.003848:0.006523:0.011738:0.006019:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.006013:0.006523:0.011738:0.012508:0.005330
following  week  can be prescribed. For :@0.084239:0.788525:0.480513:0.788525:0.480513:0.772769:0.084239:0.772769:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.003848:0.011738:0.012950:0.005330:0.006879:0.015990:0.012508:0.012508:0.009660:0.005330:0.006875:0.012450:0.013143:0.011738:0.012219:0.013123:0.012508:0.012219:0.013123:0.005715:0.012508:0.007466:0.012450:0.005792:0.003848:0.013123:0.012508:0.013181:0.005330:0.012219:0.009333:0.012604:0.005792:0.005330
locally advanced tumours  in which the :@0.084239:0.804943:0.480498:0.804943:0.480498:0.789187:0.084239:0.789187:0.003848:0.012604:0.012450:0.013143:0.003848:0.003848:0.010314:0.010987:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.010987:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005638:0.003848:0.011738:0.010987:0.015990:0.011738:0.003848:0.012450:0.011738:0.010987:0.006523:0.011738:0.012508:0.005330
mesorectal fascia is threatened by tumour :@0.084239:0.821360:0.480476:0.821360:0.480476:0.805604:0.084239:0.805604:0.018049:0.012508:0.007466:0.012604:0.005709:0.012508:0.012450:0.006523:0.013143:0.003848:0.004560:0.006042:0.013143:0.007466:0.012450:0.003848:0.013143:0.004572:0.003848:0.007466:0.004560:0.006523:0.011738:0.005707:0.012508:0.013143:0.006523:0.012508:0.011738:0.012508:0.013181:0.004560:0.013123:0.010314:0.004560:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
and downstaging is required, chemora-:@0.084239:0.837777:0.475148:0.837777:0.475148:0.822021:0.084239:0.822021:0.013143:0.011738:0.013181:0.010776:0.013181:0.012604:0.015990:0.011738:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.010776:0.003848:0.007466:0.010776:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.013181:0.005330:0.010776:0.012450:0.011738:0.012508:0.018049:0.012604:0.005792:0.013144:0.006388
diation is recommended – a dose of 45 :@0.084239:0.854195:0.480457:0.854195:0.480457:0.838439:0.084239:0.838439:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.009102:0.003848:0.007466:0.009102:0.005713:0.012508:0.012450:0.012604:0.018049:0.018049:0.012508:0.011738:0.013181:0.012508:0.013181:0.009102:0.009621:0.009102:0.013143:0.009102:0.013181:0.012604:0.007466:0.012508:0.009102:0.012604:0.006042:0.009102:0.010660:0.010660:0.005330
to 50.4 Gy in 25 to 28 fractions, given over :@0.084239:0.870612:0.480475:0.870612:0.480475:0.854856:0.084239:0.854856:0.006523:0.012604:0.005753:0.010660:0.010660:0.005330:0.010660:0.005765:0.016779:0.010314:0.005753:0.003848:0.011738:0.005753:0.010660:0.010660:0.005765:0.006523:0.012604:0.005753:0.010660:0.010660:0.005765:0.006042:0.005792:0.013143:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.005753:0.012950:0.003848:0.010660:0.012508:0.011738:0.005753:0.012604:0.010660:0.012508:0.005792:0.005330
a period of five to six weeks, with concur-:@0.084239:0.887030:0.475148:0.887030:0.475148:0.871274:0.084239:0.871274:0.013143:0.006400:0.013123:0.012508:0.005792:0.003848:0.012604:0.013181:0.006398:0.012604:0.006042:0.006394:0.004686:0.004686:0.010660:0.012508:0.006398:0.006523:0.012604:0.006392:0.007466:0.003848:0.009236:0.006406:0.015990:0.012508:0.012508:0.009660:0.007466:0.005330:0.006394:0.015990:0.003848:0.006523:0.011738:0.006398:0.012450:0.012604:0.011738:0.012450:0.011699:0.005777:0.006388
rent 5FU as a radiosensitisor. Surgery is then :@0.084239:0.903447:0.480507:0.903447:0.480507:0.887691:0.084239:0.887691:0.005713:0.012508:0.011738:0.006523:0.004832:0.010660:0.009333:0.012604:0.004839:0.013143:0.007466:0.004849:0.013143:0.004849:0.005792:0.013143:0.013181:0.003848:0.012604:0.007466:0.012508:0.011738:0.007466:0.003848:0.006523:0.003848:0.007466:0.012604:0.004383:0.005330:0.004836:0.009583:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.004832:0.003848:0.007466:0.004849:0.006523:0.011738:0.012508:0.011738:0.005330
performed six to 10 weeks later. Organ :@0.084239:0.919864:0.480488:0.919864:0.480488:0.904108:0.084239:0.904108:0.013123:0.012508:0.006710:0.006042:0.012604:0.006317:0.018049:0.012508:0.013181:0.010776:0.007466:0.003848:0.009236:0.010776:0.006523:0.012604:0.010776:0.010660:0.010660:0.010776:0.015990:0.012508:0.012508:0.009660:0.007466:0.010776:0.003848:0.013143:0.006523:0.012508:0.004380:0.005330:0.010776:0.016722:0.005809:0.012950:0.013143:0.011738:0.005330
preservation  with chemoradiation alone :@0.084239:0.936282:0.480496:0.936282:0.480496:0.920526:0.084239:0.920526:0.013123:0.005715:0.012508:0.007466:0.012508:0.005792:0.010660:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005396:0.015990:0.003848:0.006523:0.011738:0.010737:0.012450:0.011738:0.012508:0.018049:0.012604:0.005792:0.013143:0.013171:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.010737:0.013143:0.003848:0.012604:0.011738:0.012508:0.005330
is currently being investigated as a treat-:@0.523639:0.096203:0.914518:0.096203:0.914518:0.080447:0.523639:0.080447:0.003848:0.007466:0.007562:0.012450:0.011699:0.005792:0.005707:0.012508:0.011738:0.006523:0.003848:0.010314:0.007562:0.013123:0.012508:0.003848:0.011738:0.012950:0.007562:0.003848:0.011738:0.010660:0.012508:0.007466:0.006523:0.003848:0.012950:0.013143:0.006523:0.012508:0.013181:0.007562:0.013143:0.007466:0.007562:0.013143:0.007562:0.006523:0.005711:0.012508:0.013143:0.006523:0.006388
ment  option. Retrospective studies have :@0.523639:0.112502:0.919883:0.112502:0.919883:0.096746:0.523639:0.096746:0.018049:0.012508:0.011738:0.006523:0.005330:0.004031:0.012604:0.013123:0.006523:0.003848:0.012604:0.011738:0.005330:0.009371:0.011680:0.012508:0.006523:0.005709:0.012604:0.007466:0.013123:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.009371:0.007466:0.006523:0.011699:0.013181:0.003848:0.012508:0.007466:0.009371:0.011738:0.013143:0.010660:0.012508:0.005330
shown that for patients who have a com-:@0.523639:0.128800:0.914554:0.128800:0.914554:0.113044:0.523639:0.113044:0.007466:0.011738:0.012604:0.015990:0.011738:0.006159:0.006523:0.011738:0.013143:0.006523:0.006161:0.006042:0.012604:0.005792:0.006154:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006165:0.015990:0.011738:0.012604:0.006159:0.011738:0.013143:0.010660:0.012508:0.006163:0.013143:0.006165:0.012450:0.012604:0.018049:0.006388
plete response to neoadjuvant chemora-:@0.523639:0.145098:0.914549:0.145098:0.914549:0.129342:0.523639:0.129342:0.013123:0.003848:0.012508:0.006523:0.012508:0.006664:0.005713:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.012508:0.006664:0.006523:0.012604:0.006658:0.011738:0.012508:0.012604:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.006662:0.012450:0.011738:0.012508:0.018049:0.012604:0.005792:0.013129:0.006388
diation, surgery may be avoided and this :@0.523639:0.161397:0.919900:0.161397:0.919900:0.145641:0.523639:0.145641:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.006716:0.007466:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.006702:0.018049:0.013143:0.010314:0.006716:0.013123:0.012508:0.006716:0.013143:0.010660:0.012604:0.003848:0.013181:0.012508:0.013181:0.006716:0.013143:0.011738:0.013181:0.006716:0.006523:0.011738:0.003848:0.007466:0.005330
treatment  option  is especially attractive :@0.523639:0.177695:0.919886:0.177695:0.919886:0.161939:0.523639:0.161939:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005099:0.012604:0.013123:0.006523:0.003848:0.012604:0.011738:0.005330:0.005101:0.003848:0.007466:0.010449:0.012508:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003860:0.003848:0.010314:0.010449:0.013143:0.006523:0.006523:0.005792:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330
for patients requiring APR.  At present, it :@0.523639:0.193993:0.919881:0.193961:0.919881:0.178205:0.523639:0.178237:0.006042:0.012604:0.005792:0.008207:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008217:0.005713:0.012508:0.013123:0.011699:0.003848:0.005792:0.003848:0.011738:0.012950:0.008217:0.014239:0.011392:0.011680:0.005330:0.012416:0.008217:0.014239:0.006523:0.008217:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.005330:0.008207:0.003848:0.006523:0.280786
11:@0.771432:0.188342:0.783862:0.188342:0.783862:0.179156:0.771432:0.179156:0.006215:0.006215
is recommended that chemoradiation fol-:@0.523632:0.210259:0.914553:0.210259:0.914553:0.194503:0.523632:0.194503:0.003848:0.007466:0.004791:0.005711:0.012508:0.012450:0.012604:0.018049:0.018049:0.012508:0.011738:0.013181:0.012508:0.013181:0.004791:0.006523:0.011738:0.013143:0.006523:0.004782:0.012450:0.011738:0.012508:0.018049:0.012604:0.005778:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.004791:0.006042:0.012604:0.003848:0.006388
lowed by watchful waiting be undertaken :@0.523632:0.226557:0.919910:0.226557:0.919910:0.210801:0.523632:0.210801:0.003848:0.012604:0.015990:0.012508:0.013181:0.005157:0.013123:0.010314:0.005157:0.015990:0.013143:0.006523:0.012450:0.011738:0.006042:0.011699:0.003848:0.005157:0.015990:0.013143:0.003848:0.006523:0.003848:0.011738:0.012950:0.005157:0.013123:0.012508:0.005157:0.011699:0.011738:0.013181:0.012508:0.005792:0.006523:0.013143:0.009660:0.012508:0.011738:0.005330
only in the context of a clinical trial.:@0.523632:0.242856:0.852831:0.242856:0.852831:0.227100:0.523632:0.227100:0.012604:0.011738:0.003848:0.010314:0.005330:0.003848:0.011738:0.005330:0.006523:0.011738:0.012508:0.005330:0.012450:0.012604:0.011738:0.006523:0.012508:0.009236:0.006523:0.005330:0.012604:0.006042:0.005330:0.013143:0.005330:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.006523:0.005792:0.003848:0.013143:0.003848:0.005330
TREATMENT OF METASTATIC :@0.523636:0.276104:0.833139:0.276104:0.833139:0.256507:0.523636:0.256507:0.009878:0.013641:0.012230:0.017404:0.009878:0.021167:0.012230:0.017404:0.009878:0.006585:0.019756:0.011289:0.006585:0.021167:0.012230:0.009878:0.017404:0.012230:0.009878:0.017404:0.009878:0.006585:0.018344:0.006585
DISEASE:@0.523636:0.295345:0.613006:0.295345:0.613006:0.275748:0.523636:0.275748:0.016463:0.006585:0.012230:0.012230:0.017404:0.012230:0.012230
Metastatic disease is present in about 25% :@0.523636:0.313935:0.919875:0.313935:0.919875:0.298179:0.523636:0.298179:0.017684:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005195:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005195:0.003848:0.007466:0.005195:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.005195:0.003848:0.011738:0.005195:0.013143:0.013123:0.012604:0.011699:0.006523:0.005195:0.010660:0.010660:0.014913:0.005330
of patients at initial presentation and a fur-:@0.523636:0.330233:0.914549:0.330233:0.914549:0.314477:0.523636:0.314477:0.012604:0.006042:0.004620:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004626:0.013143:0.006523:0.004622:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.003848:0.004637:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.004614:0.013143:0.011738:0.013181:0.004624:0.013143:0.004626:0.006042:0.011699:0.005792:0.006388
ther  25% will develop metastatic disease :@0.523636:0.346531:0.919860:0.346531:0.919860:0.330775:0.523636:0.330775:0.006523:0.011738:0.012508:0.005792:0.005330:0.003025:0.010660:0.010660:0.014913:0.008370:0.015990:0.003848:0.003848:0.003848:0.008370:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.008370:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.008370:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
after treatment of the primary tumour, :@0.523636:0.362830:0.919897:0.362830:0.919897:0.347074:0.523636:0.347074:0.013143:0.006042:0.006523:0.012508:0.005792:0.012912:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.012912:0.012604:0.006042:0.012912:0.006523:0.011738:0.012508:0.012912:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.012912:0.006523:0.011699:0.018049:0.012604:0.011699:0.003758:0.005330:0.005330
the most common sites being liver, perito-:@0.523636:0.379128:0.914570:0.379128:0.914570:0.363372:0.523636:0.363372:0.006523:0.011738:0.012508:0.006215:0.018049:0.012604:0.007466:0.006523:0.006215:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.006215:0.007466:0.003848:0.006523:0.012508:0.007466:0.006215:0.013123:0.012508:0.003848:0.011738:0.012950:0.006215:0.003848:0.003848:0.010660:0.012508:0.003777:0.005330:0.006215:0.013123:0.012508:0.005792:0.003848:0.006523:0.012604:0.006388
neum, distant nodes, lung and bone. The :@0.523636:0.395426:0.919875:0.395426:0.919875:0.379670:0.523636:0.379670:0.011738:0.012508:0.011699:0.018049:0.005330:0.006716:0.013181:0.003848:0.007466:0.006523:0.013143:0.011738:0.006523:0.006716:0.011738:0.012604:0.013181:0.012508:0.007466:0.005330:0.006716:0.003848:0.011699:0.011738:0.012950:0.006716:0.013143:0.011738:0.013181:0.006716:0.013123:0.012604:0.011738:0.012508:0.005330:0.006716:0.008197:0.011738:0.012508:0.005330
prognosis of patients with metastatic dis-:@0.523636:0.411725:0.914526:0.411725:0.914526:0.395969:0.523636:0.395969:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.008140:0.012604:0.006042:0.008140:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008140:0.015990:0.003848:0.006523:0.011738:0.008140:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.008140:0.013181:0.003848:0.007466:0.006388
ease has improved substantially since the :@0.523636:0.428023:0.919854:0.428023:0.919854:0.412267:0.523636:0.412267:0.012508:0.013143:0.007466:0.012508:0.006350:0.011738:0.013143:0.007466:0.006350:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.013181:0.006350:0.007466:0.011699:0.013123:0.007466:0.006523:0.013143:0.011738:0.006523:0.003848:0.013143:0.003848:0.003848:0.010314:0.006363:0.007466:0.003848:0.011738:0.012450:0.012508:0.006350:0.006523:0.011738:0.012508:0.005330
1980s due to the development of surgical :@0.523636:0.444321:0.919866:0.444321:0.919866:0.428565:0.523636:0.428565:0.010660:0.010660:0.010660:0.010660:0.007466:0.006081:0.013181:0.011699:0.012508:0.006065:0.006523:0.012604:0.006061:0.006523:0.011738:0.012508:0.006065:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.018049:0.012508:0.011738:0.006523:0.006065:0.012604:0.006042:0.006063:0.007466:0.011699:0.005807:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330
techniques and new systemic agents. In :@0.523636:0.460620:0.919875:0.460620:0.919875:0.444864:0.523636:0.444864:0.006523:0.012508:0.012450:0.011738:0.011738:0.003848:0.013123:0.011699:0.012508:0.007466:0.008928:0.013143:0.011738:0.013181:0.008928:0.011738:0.012508:0.015990:0.008928:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.003848:0.012450:0.008928:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.008928:0.004349:0.011738:0.005330
a review of patients treated at two large :@0.523636:0.476918:0.919887:0.476918:0.919887:0.461162:0.523636:0.461162:0.013143:0.007129:0.005713:0.012508:0.010660:0.003848:0.012508:0.015990:0.007139:0.012604:0.006042:0.007124:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.007129:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.007124:0.013143:0.006523:0.007127:0.006523:0.015990:0.012604:0.007122:0.003848:0.013143:0.005811:0.012950:0.012508:0.005330
centres in the US, the median overall sur-:@0.523636:0.493216:0.914555:0.493216:0.914555:0.477460:0.523636:0.477460:0.012450:0.012508:0.011738:0.006523:0.005705:0.012508:0.007466:0.007312:0.003848:0.011738:0.007312:0.006523:0.011738:0.012508:0.007302:0.012604:0.009583:0.005330:0.007312:0.006523:0.011738:0.012508:0.007302:0.018049:0.012508:0.013181:0.003848:0.013143:0.011738:0.007312:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.007312:0.007466:0.011699:0.005792:0.006388
vival for patients with metastatic disease :@0.523636:0.509515:0.919875:0.509515:0.919875:0.493759:0.523636:0.493759:0.010660:0.003848:0.010660:0.013143:0.003848:0.008217:0.006042:0.012604:0.005792:0.008201:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008207:0.015990:0.003848:0.006523:0.011738:0.008203:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.008217:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
increased from 14.2  months in the early :@0.523636:0.525813:0.919864:0.525813:0.919864:0.510057:0.523636:0.510057:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.009756:0.006042:0.005711:0.012604:0.018049:0.009756:0.010660:0.010660:0.005330:0.010660:0.005330:0.004439:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.009756:0.003848:0.011738:0.009756:0.006523:0.011738:0.012508:0.009756:0.012508:0.013143:0.005792:0.003848:0.010314:0.005330
1990s to  29.3 months  for  the  time  period :@0.523636:0.542111:0.919877:0.542111:0.919877:0.526355:0.523636:0.526355:0.010660:0.010660:0.010660:0.010660:0.007466:0.008447:0.006523:0.012604:0.005330:0.003108:0.010660:0.010660:0.005330:0.010660:0.008447:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330:0.003098:0.006042:0.012604:0.005792:0.005330:0.003100:0.006523:0.011738:0.012508:0.005330:0.003100:0.006523:0.003848:0.018049:0.012508:0.005330:0.003106:0.013123:0.012508:0.005792:0.003848:0.012604:0.013181:0.005330
between 2004 and 2006.:@0.523636:0.558410:0.753198:0.558410:0.753198:0.542654:0.523636:0.542654:0.013123:0.012508:0.006523:0.015990:0.012508:0.012508:0.011738:0.005330:0.010660:0.010660:0.010660:0.010660:0.005330:0.013143:0.011738:0.013181:0.005330:0.010660:0.010660:0.010660:0.010660:0.005330
12:@0.753210:0.552803:0.765640:0.552803:0.765640:0.543618:0.753210:0.543618:0.006215:0.006215
SURGERY:@0.523636:0.591344:0.615572:0.591344:0.615572:0.573529:0.523636:0.573529:0.011118:0.013683:0.012401:0.017960:0.011118:0.012401:0.013256
The only potentially curative treatment :@0.523636:0.608790:0.919891:0.608790:0.919891:0.593034:0.523636:0.593034:0.008005:0.011545:0.012315:0.014663:0.012411:0.011545:0.003656:0.010122:0.014663:0.012931:0.012411:0.006331:0.012315:0.011545:0.006331:0.003656:0.012950:0.003656:0.003656:0.010122:0.014663:0.012257:0.011507:0.005600:0.012950:0.006331:0.003656:0.010468:0.012315:0.014663:0.006331:0.005521:0.012315:0.012950:0.006331:0.017857:0.012315:0.011545:0.006521:0.005330
for metastatic disease involves surgery. :@0.523636:0.625088:0.919885:0.625088:0.919885:0.609332:0.523636:0.609332:0.005850:0.012411:0.005600:0.014432:0.017857:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.006331:0.003656:0.012257:0.014432:0.012989:0.003656:0.007274:0.012315:0.012950:0.007274:0.012315:0.014432:0.003656:0.011545:0.010468:0.012411:0.003656:0.010468:0.012315:0.007274:0.014432:0.007274:0.011507:0.005613:0.012758:0.012315:0.005600:0.010122:0.005326:0.005330
Therefore it is essential that all patients :@0.523636:0.641387:0.919914:0.641387:0.919914:0.625631:0.523636:0.625631:0.008005:0.011545:0.012315:0.005521:0.012315:0.005850:0.012411:0.005521:0.012315:0.012662:0.003656:0.006331:0.012662:0.003656:0.007274:0.012662:0.012315:0.007274:0.007274:0.012315:0.011545:0.006331:0.003656:0.012950:0.003656:0.012662:0.006331:0.011545:0.012950:0.006331:0.012662:0.012950:0.003656:0.003656:0.012662:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007470:0.005330
with metastases who are fit for surgery be :@0.523636:0.657685:0.919891:0.657685:0.919891:0.641929:0.523636:0.641929:0.015798:0.003656:0.006331:0.011545:0.007170:0.017857:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.007274:0.012315:0.007274:0.007170:0.015798:0.011545:0.012411:0.007170:0.012950:0.005521:0.012315:0.007170:0.004589:0.004589:0.006331:0.007170:0.005850:0.012411:0.005600:0.007170:0.007274:0.011507:0.005615:0.012758:0.012315:0.005600:0.010122:0.007170:0.012931:0.012506:0.005330
evaluated for possible metastatectomy, :@0.523636:0.673983:0.919893:0.673983:0.919893:0.658227:0.523636:0.658227:0.012315:0.010468:0.012950:0.003656:0.011507:0.012950:0.006331:0.012315:0.012989:0.013393:0.005850:0.012411:0.005600:0.013393:0.012931:0.012411:0.007274:0.007274:0.003656:0.012931:0.003656:0.012315:0.013393:0.017857:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.006331:0.012315:0.012257:0.006331:0.012411:0.017857:0.010122:0.005328:0.005330
ideally in a multidisciplinary team setting. In :@0.523636:0.690282:0.919854:0.690282:0.919854:0.674526:0.523636:0.674526:0.003656:0.012989:0.012315:0.012950:0.003656:0.003656:0.010122:0.004907:0.003656:0.011545:0.004897:0.012950:0.004907:0.017857:0.011507:0.003656:0.006331:0.003656:0.012989:0.003656:0.007274:0.012257:0.003656:0.012931:0.003656:0.003656:0.011545:0.012950:0.005600:0.010122:0.004897:0.006331:0.012315:0.012950:0.017857:0.004897:0.007274:0.012315:0.006331:0.006331:0.003656:0.011545:0.012758:0.005138:0.004897:0.004156:0.011736:0.005330
general, as long as 25-30% of the original :@0.523636:0.706580:0.919899:0.706580:0.919899:0.690824:0.523636:0.690824:0.012758:0.012315:0.011545:0.012315:0.005600:0.012950:0.003656:0.005138:0.008024:0.012950:0.007274:0.008024:0.003656:0.012411:0.011545:0.012758:0.008024:0.012950:0.007274:0.008024:0.010468:0.010468:0.006196:0.010468:0.010468:0.014720:0.008024:0.012411:0.005850:0.008024:0.006331:0.011545:0.012315:0.008024:0.012411:0.005600:0.003656:0.012758:0.003656:0.011545:0.012950:0.003852:0.005330
liver volume can be spared, in a liver with :@0.523636:0.722878:0.919852:0.722878:0.919852:0.707122:0.523636:0.707122:0.003656:0.003656:0.010468:0.012315:0.005600:0.006812:0.010468:0.012411:0.003656:0.011507:0.017857:0.012315:0.006812:0.012257:0.012950:0.011545:0.006812:0.012931:0.012315:0.006812:0.007274:0.012931:0.012950:0.005521:0.012315:0.012989:0.005138:0.006812:0.003656:0.011545:0.006812:0.012950:0.006812:0.003656:0.003656:0.010468:0.012315:0.005600:0.006812:0.015798:0.003656:0.006331:0.011736:0.005330
normal function, resection of liver metasta-:@0.523636:0.739177:0.914574:0.739177:0.914574:0.723421:0.523636:0.723421:0.011545:0.012411:0.006131:0.017857:0.012950:0.003656:0.005234:0.005850:0.011507:0.011545:0.012257:0.006331:0.003656:0.012411:0.011545:0.005138:0.005234:0.005521:0.012315:0.007274:0.012315:0.012257:0.006331:0.003656:0.012411:0.011545:0.005234:0.012411:0.005850:0.005234:0.003656:0.003656:0.010468:0.012315:0.005600:0.005234:0.017857:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.006388
ses is possible. Limited lung metastases are :@0.523636:0.755475:0.919872:0.755475:0.919872:0.739719:0.523636:0.739719:0.007274:0.012315:0.007274:0.006119:0.003656:0.007274:0.006119:0.012931:0.012411:0.007274:0.007274:0.003656:0.012931:0.003656:0.012315:0.005138:0.006119:0.008698:0.003656:0.017857:0.003656:0.006331:0.012315:0.012989:0.006119:0.003656:0.011507:0.011545:0.012758:0.006119:0.017857:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.007274:0.012315:0.007274:0.006119:0.012950:0.005521:0.012506:0.005330
also potentially resectable. Local ablative :@0.523636:0.771773:0.919833:0.771773:0.919833:0.756017:0.523636:0.756017:0.012950:0.003656:0.007274:0.012411:0.007562:0.012931:0.012411:0.006331:0.012315:0.011545:0.006331:0.003656:0.012950:0.003656:0.003656:0.010122:0.007562:0.005521:0.012315:0.007274:0.012315:0.012257:0.006331:0.012950:0.012931:0.003656:0.012315:0.005138:0.007562:0.008698:0.012411:0.012257:0.012950:0.003656:0.007562:0.012950:0.012931:0.003656:0.012950:0.006331:0.003656:0.010468:0.012506:0.005330
techniques such  as  microwave and  radi-:@0.523636:0.788072:0.914551:0.788072:0.914551:0.772316:0.523636:0.772316:0.006331:0.012315:0.012257:0.011545:0.011545:0.003656:0.012931:0.011507:0.012315:0.007274:0.008832:0.007274:0.011507:0.012257:0.011545:0.005330:0.003492:0.012950:0.007274:0.005330:0.003492:0.017857:0.003656:0.012257:0.005519:0.012411:0.015798:0.012950:0.010468:0.012315:0.008832:0.012950:0.011545:0.012989:0.005330:0.003492:0.005600:0.012950:0.012989:0.003656:0.006388
ofrequency ablation as well as stereotac-:@0.523636:0.804370:0.914522:0.804370:0.914522:0.788614:0.523636:0.788614:0.012411:0.005850:0.005521:0.012315:0.012931:0.011507:0.012315:0.011545:0.012257:0.010122:0.007543:0.012950:0.012931:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.007543:0.012950:0.007274:0.007543:0.015798:0.012315:0.003656:0.003656:0.007543:0.012950:0.007274:0.007543:0.007274:0.006331:0.012315:0.005521:0.012315:0.012411:0.006331:0.012950:0.012257:0.006388
tic body radiation can be used in patients :@0.523636:0.820668:0.919879:0.820668:0.919879:0.804912:0.523636:0.804912:0.006331:0.003656:0.012257:0.006186:0.012931:0.012411:0.012989:0.010122:0.006196:0.005600:0.012950:0.012989:0.003656:0.012950:0.006331:0.003656:0.012411:0.011545:0.006186:0.012257:0.012950:0.011545:0.006186:0.012931:0.012315:0.006186:0.011507:0.007274:0.012315:0.012989:0.006186:0.003656:0.011545:0.006186:0.012931:0.012950:0.006331:0.003656:0.012315:0.011545:0.006331:0.007470:0.005330
who are not surgical candidates. Metasta-:@0.523636:0.836967:0.914559:0.836967:0.914559:0.821211:0.523636:0.821211:0.015798:0.011545:0.012411:0.005600:0.012950:0.005521:0.012315:0.005600:0.011545:0.012411:0.006331:0.005600:0.007274:0.011507:0.005615:0.012758:0.003656:0.012257:0.012950:0.003656:0.005600:0.012257:0.012950:0.011545:0.012989:0.003656:0.012989:0.012950:0.006331:0.012315:0.007274:0.005138:0.005600:0.017491:0.012315:0.006331:0.012950:0.007274:0.006331:0.012950:0.006388
ses to bone, peritoneum or distant nodes :@0.523636:0.853265:0.919916:0.853265:0.919916:0.837509:0.523636:0.837509:0.007274:0.012315:0.007274:0.008120:0.006331:0.012411:0.008120:0.012931:0.012411:0.011545:0.012315:0.005138:0.008120:0.012931:0.012315:0.005600:0.003656:0.006331:0.012411:0.011545:0.012315:0.011507:0.017857:0.008120:0.012411:0.005600:0.008120:0.012989:0.003656:0.007274:0.006331:0.012950:0.011545:0.006331:0.008120:0.011545:0.012411:0.012989:0.012315:0.007468:0.005330
are usually not considered for resection.:@0.523636:0.869563:0.887156:0.869563:0.887156:0.853807:0.523636:0.853807:0.012950:0.005521:0.012315:0.005138:0.011507:0.007274:0.011507:0.012950:0.003656:0.003656:0.010122:0.005138:0.011545:0.012411:0.006331:0.005138:0.012257:0.012411:0.011545:0.007274:0.003656:0.012989:0.012315:0.005521:0.012315:0.012989:0.005138:0.005850:0.012411:0.005600:0.005138:0.005519:0.012315:0.007274:0.012315:0.012257:0.006331:0.003656:0.012411:0.011545:0.005330
CHEMOTHERAPY:@0.523636:0.902499:0.691259:0.902499:0.691259:0.884684:0.523636:0.884684:0.016677:0.014539:0.011118:0.019242:0.017960:0.008980:0.014539:0.011118:0.012401:0.015822:0.011973:0.013256
Chemotherapy  can  be  used  together :@0.523636:0.919945:0.919897:0.919945:0.919897:0.904189:0.523636:0.904189:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.009233:0.012450:0.013143:0.011738:0.005330:0.009242:0.013123:0.012508:0.005330:0.009246:0.011699:0.007466:0.012508:0.013181:0.005330:0.009246:0.006523:0.012604:0.012950:0.012508:0.006523:0.011738:0.012508:0.005792:0.005330
with surgery  to downstage  patients with :@0.523636:0.936243:0.919889:0.936243:0.919889:0.920487:0.523636:0.920487:0.015990:0.003848:0.006523:0.011738:0.009621:0.007466:0.011699:0.005807:0.012950:0.012508:0.005792:0.010314:0.005330:0.004281:0.006523:0.012604:0.009621:0.013181:0.012604:0.015990:0.011738:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.004280:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009621:0.015990:0.003848:0.006523:0.011738:0.005330